Survival Benefits of Neoadjuvant Systemic Chemotherapy in Muscle Invasive Bladder Cancer

Clinical trial NCT06727214 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06727214
Sponsor: Sara Mahmoud Ahmed Mahmoud
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Bladder Urothelial Carcinoma

Start date: 2025-11-04
Primary completion: 2026-11-04
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.